Aspo (ASPO) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
2 Nov, 2026Executive summary
Q3 comparable EBITA from continuing operations rose to EUR 8.5m from EUR 7.6m; Telko improved while ESL Shipping declined.
9M comparable EBITA from continuing operations increased to EUR 26.4m from EUR 22.4m.
Preparations advanced for a planned partial demerger of ESL Shipping, with completion targeted for Dec. 31, 2026, subject to shareholder approval and other conditions.
Financial highlights
Q3 continuing-operations net sales were EUR 134.2m, up 24.2% YoY; 9M net sales were EUR 379.4m vs EUR 349.8m.
9M total EBITA was EUR 37.3m vs EUR 26.9m; comparable EBITA margin was 7.0% vs 6.4%.
9M comparable EPS from continuing operations was EUR 0.65 vs EUR 0.33; total EPS was EUR 0.99 vs EUR 0.43.
9M free cash flow was EUR 33.2m vs EUR 0.3m, including EUR 58.1m net cash inflow from the Leipurin divestment and EUR 44.2m of investments.
9M profit was EUR 32.1m, including an EUR 11.8m gain on the Leipurin divestment; Q3 reported EBITA from continuing operations was EUR 7.5m vs EUR 8.6m.
Outlook and guidance
FY2026 comparable EBITA from continuing operations is expected to exceed 2025's EUR 29.4m; transformation execution costs are excluded.
Improvement is expected from segment initiatives, Telko synergies, ESL fleet renewal and utilization, and lower central costs.
ESL expects Q4 demand and spot pricing to improve; Telko expects underlying volumes stable or slightly higher YoY and prices stable at current levels, with volatility possible.
Latest events from Aspo
- Q1 growth and profit gains support a €1bn sales and 8% EBITA ambition for 2028.ASPO
Investor presentation - A planned demerger sets up two distinct growth stories and investment profiles.ASPO
Investor presentation - FY comparable profit fell to EUR 26.5 million; 2024 guidance is above EUR 30 million.ASPO
Q4 2023 - AGM approved a EUR 0.25 dividend and broad share repurchase and issuance mandates.ASPO
AGM 2026 - Profitability surged in H1 2026, with a demerger and Leipurin divestment driving growth.ASPO
Q2 2026 - Stable EBITA and strong cash flow driven by Leipurin divestment and strategic transformation.ASPO
Q1 2026 - Q2 2024 saw 16% sales growth, improved profitability, and major strategic acquisitions.ASPO
Q2 2024 - Q1 2025 saw robust sales and profit growth, driven by acquisitions and efficiency gains.ASPO
Q1 2025 - Sales and EBITA grew in 2024, with heavy green investments and a positive 2025 outlook.ASPO
Q4 2024